EE200100221A - Sertraliini oraalne kontsentraat - Google Patents

Sertraliini oraalne kontsentraat

Info

Publication number: EE200100221A
Authority: EE; Estonia
Prior art keywords: oral concentrate; sertraline oral; sertraline; concentrate; oral
Prior art date: 1998-10-13

Application number

EEP200100221A

Other languages

English (en)

Inventor

Jane Harper Nancy

Ramchandra Ranade Gautam

Mckowan Welch Willard

Original Assignee

Pfizer Products Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-13

Filing date

1999-09-22

Publication date

2002-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22298286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200100221(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-09-22 Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.

2002-08-15 Publication of EE200100221A publication Critical patent/EE200100221A/et

2007-08-15 Publication of EE04868B1 publication Critical patent/EE04868B1/et

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Hematology (AREA)
Child & Adolescent Psychology (AREA)
Pain & Pain Management (AREA)
Addiction (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Obesity (AREA)
Vascular Medicine (AREA)
Nutrition Science (AREA)
Oil, Petroleum & Natural Gas (AREA)
Urology & Nephrology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

EEP200100221A 1998-10-13 1999-09-22 Farmatseutiline kompositsioon, mis sisaldab vett mittesisaldavat, vedelat kontsentraati oraalseks manustamiseks, mis sisaldab sertraliini v?i selle farmatseutiliselt vastuv?etava soola kogust ning hte v?i rohkemat vett mittesisaldavat farmatseutilis EE04868B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10402498P	1998-10-13	1998-10-13
PCT/IB1999/001571 WO2000021521A2 (en)	1998-10-13	1999-09-22	Sertraline oral concentrate

Publications (2)

Publication Number	Publication Date
EE200100221A true EE200100221A (et)	2002-08-15
EE04868B1 EE04868B1 (et)	2007-08-15

Family

ID=22298286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100221A EE04868B1 (et)	1998-10-13	1999-09-22	Farmatseutiline kompositsioon, mis sisaldab vett mittesisaldavat, vedelat kontsentraati oraalseks manustamiseks, mis sisaldab sertraliini v?i selle farmatseutiliselt vastuv?etava soola kogust ning hte v?i rohkemat vett mittesisaldavat farmatseutilis

Country Status (46)

Country	Link
EP (1)	EP1121107B1 (et)
JP (1)	JP3792514B2 (et)
KR (1)	KR100417200B1 (et)
CN (1)	CN1184962C (et)
AP (1)	AP2001002119A0 (et)
AR (1)	AR014082A1 (et)
AT (1)	ATE254453T1 (et)
AU (1)	AU766202B2 (et)
BG (1)	BG65085B1 (et)
BR (1)	BR9914418A (et)
CA (1)	CA2346335C (et)
CO (1)	CO5150213A1 (et)
CZ (1)	CZ20011286A3 (et)
DE (1)	DE69912978T2 (et)
DK (1)	DK1121107T3 (et)
DZ (1)	DZ2913A1 (et)
EA (1)	EA003990B1 (et)
EE (1)	EE04868B1 (et)
EG (1)	EG23818A (et)
ES (1)	ES2209490T3 (et)
GC (1)	GC0000175A (et)
GE (1)	GEP20032969B (et)
GT (1)	GT199900171A (et)
HK (1)	HK1040199B (et)
HR (1)	HRP20010263B1 (et)
HU (1)	HUP0104470A3 (et)
ID (1)	ID29845A (et)
IS (1)	IS2239B (et)
MA (1)	MA26698A1 (et)
MY (1)	MY122477A (et)
NO (1)	NO20011829L (et)
NZ (1)	NZ510756A (et)
OA (1)	OA11662A (et)
PA (1)	PA8483301A1 (et)
PE (1)	PE20001108A1 (et)
PL (1)	PL348119A1 (et)
PT (1)	PT1121107E (et)
PY (1)	PY990106A (et)
SK (1)	SK4582001A3 (et)
TN (1)	TNSN99190A1 (et)
TR (1)	TR200101090T2 (et)
TW (1)	TWI228043B (et)
UA (1)	UA72743C2 (et)
WO (1)	WO2000021521A2 (et)
YU (1)	YU26401A (et)
ZA (1)	ZA200102900B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1671628B1 (en)	1999-09-03	2012-10-03	APBI Holdings, LLC	Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
US20030086972A1 (en) *	2000-08-09	2003-05-08	Appel Leah E.	Hydrogel-driven drug dosage form
WO2004065348A1 (en)	2003-01-23	2004-08-05	Pfizer Products Inc.	Pharmaceutically acceptable salts of sertraline and pharmaceutical compositions thereof
JP2007502329A (ja)	2003-05-23	2007-02-08	トランスフォーム・ファーマシューティカルズ・インコーポレイテッド	セルトラリン組成物
WO2005034910A1 (en) *	2003-10-08	2005-04-21	Ranbaxy Laboratories Limited	Oral liquid pharmaceutical compositions of sertraline
WO2007052152A2 (en) *	2005-11-07	2007-05-10	Aurobindo Pharma Limited	Sertraline oral concentrate
WO2008112641A2 (en) *	2007-03-09	2008-09-18	New York University	Methods and compositions for treating thalamocortical dysrhythmia
CN109908354A (zh) *	2017-12-12	2019-06-21	万特制药(海南)有限公司	盐酸舍曲林口服浓缩液及其制备工艺
CN114225038A (zh) *	2021-06-02	2022-03-25	青海春天药用资源科技股份有限公司	酒精和凉味剂组合物在调节性功能、护血管、肝细胞再生、抗肿瘤、提高免疫及睡眠的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4940731A (en) *	1989-08-30	1990-07-10	Pfizer Inc.	Method of treating premature ejaculation using sertraline
US5130338A (en) *	1989-08-30	1992-07-14	Pfizer Inc.	Method of treating chemical dependencies using sertraline
DE69004529T2 (de) *	1989-08-30	1994-02-24	Pfizer	Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
US4962128A (en) *	1989-11-02	1990-10-09	Pfizer Inc.	Method of treating anxiety-related disorders using sertraline
CA2143070C (en) *	1994-02-22	2001-12-18	Pankaj Modi	Oral controlled release liquid suspension pharmaceutical formulation
US5597826A (en) *	1994-09-14	1997-01-28	Pfizer Inc.	Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
SE508372C2 (sv) *	1995-02-13	1998-09-28	Kjell Lindstroem	Metod och utrustning för tillförsel eller aspiration av substanser inom gastrointestinalkanalen, avsedd för mätning av farmakokinetiska och fysikalisk-kemiska parametrar
ATE235237T1 (de) *	1995-07-17	2003-04-15	Pfizer	Sertralin zur behandlung von post-myocard-infarkt-patienten
TR199903282T2 (xx) *	1997-07-01	2000-08-21	Pfizer Products Inc.	Sertralin'in jelatin ile kaps�llenmi� ��zelti dozaj �ekli.

1999
- 1999-09-22 UA UA2001042450A patent/UA72743C2/uk unknown
- 1999-09-22 CA CA002346335A patent/CA2346335C/en not_active Expired - Fee Related
- 1999-09-22 GE GEAP19995852A patent/GEP20032969B/en unknown
- 1999-09-22 AU AU56436/99A patent/AU766202B2/en not_active Ceased
- 1999-09-22 HU HU0104470A patent/HUP0104470A3/hu unknown
- 1999-09-22 OA OA1200100087A patent/OA11662A/en unknown
- 1999-09-22 ES ES99943168T patent/ES2209490T3/es not_active Expired - Lifetime
- 1999-09-22 EA EA200100285A patent/EA003990B1/ru not_active IP Right Cessation
- 1999-09-22 PT PT99943168T patent/PT1121107E/pt unknown
- 1999-09-22 SK SK458-2001A patent/SK4582001A3/sk unknown
- 1999-09-22 BR BR9914418-2A patent/BR9914418A/pt not_active Application Discontinuation
- 1999-09-22 AT AT99943168T patent/ATE254453T1/de not_active IP Right Cessation
- 1999-09-22 CZ CZ20011286A patent/CZ20011286A3/cs unknown
- 1999-09-22 DE DE69912978T patent/DE69912978T2/de not_active Expired - Fee Related
- 1999-09-22 KR KR10-2001-7004559A patent/KR100417200B1/ko not_active Expired - Fee Related
- 1999-09-22 CN CNB998120871A patent/CN1184962C/zh not_active Expired - Fee Related
- 1999-09-22 HK HK02101974.6A patent/HK1040199B/zh not_active IP Right Cessation
- 1999-09-22 JP JP2000575497A patent/JP3792514B2/ja not_active Expired - Fee Related
- 1999-09-22 WO PCT/IB1999/001571 patent/WO2000021521A2/en not_active Ceased
- 1999-09-22 ID IDW20010824A patent/ID29845A/id unknown
- 1999-09-22 EE EEP200100221A patent/EE04868B1/et not_active IP Right Cessation
- 1999-09-22 PL PL99348119A patent/PL348119A1/xx not_active Application Discontinuation
- 1999-09-22 NZ NZ510756A patent/NZ510756A/en unknown
- 1999-09-22 DK DK99943168T patent/DK1121107T3/da active
- 1999-09-22 AP APAP/P/2001/002119A patent/AP2001002119A0/en unknown
- 1999-09-22 EP EP99943168A patent/EP1121107B1/en not_active Expired - Lifetime
- 1999-09-22 HR HR20010263A patent/HRP20010263B1/xx not_active IP Right Cessation
- 1999-09-22 TR TR2001/01090T patent/TR200101090T2/xx unknown
- 1999-09-22 YU YU26401A patent/YU26401A/sh unknown
- 1999-09-28 PA PA19998483301A patent/PA8483301A1/es unknown
- 1999-09-30 PY PY199909900106A patent/PY990106A/es unknown
- 1999-10-05 GT GT199900171A patent/GT199900171A/es unknown
- 1999-10-06 TW TW088117244A patent/TWI228043B/zh not_active IP Right Cessation
- 1999-10-08 AR ARP990105116A patent/AR014082A1/es unknown
- 1999-10-09 GC GCP1999314 patent/GC0000175A/en active
- 1999-10-11 PE PE1999001025A patent/PE20001108A1/es not_active Application Discontinuation
- 1999-10-11 MY MYPI99004384A patent/MY122477A/en unknown
- 1999-10-12 MA MA25814A patent/MA26698A1/fr unknown
- 1999-10-12 EG EG127599A patent/EG23818A/xx active
- 1999-10-12 TN TNTNSN99190A patent/TNSN99190A1/fr unknown
- 1999-10-12 DZ DZ990213A patent/DZ2913A1/xx active
- 1999-10-13 CO CO99065089A patent/CO5150213A1/es unknown
2001
- 2001-03-23 IS IS5906A patent/IS2239B/is unknown
- 2001-04-09 ZA ZA200102900A patent/ZA200102900B/xx unknown
- 2001-04-10 NO NO20011829A patent/NO20011829L/no not_active Application Discontinuation
- 2001-04-10 BG BG105434A patent/BG65085B1/bg unknown

Also Published As

Publication number	Publication date
ES2209490T3 (es)	2004-06-16
TNSN99190A1 (fr)	2005-11-10
PE20001108A1 (es)	2000-10-26
HRP20010263B1 (en)	2005-04-30
JP2002527385A (ja)	2002-08-27
CA2346335A1 (en)	2000-04-20
WO2000021521A2 (en)	2000-04-20
ZA200102900B (en)	2002-05-29
EP1121107B1 (en)	2003-11-19
OA11662A (en)	2004-12-08
HRP20010263A2 (en)	2002-06-30
GT199900171A (es)	2001-03-28
DK1121107T3 (da)	2004-02-23
HUP0104470A3 (en)	2003-12-29
ID29845A (id)	2001-10-18
DE69912978D1 (de)	2003-12-24
BG65085B1 (bg)	2007-02-28
IS5906A (is)	2001-03-23
BR9914418A (pt)	2001-06-26
CA2346335C (en)	2006-04-18
EG23818A (en)	2007-09-19
AU766202B2 (en)	2003-10-09
CN1323202A (zh)	2001-11-21
CN1184962C (zh)	2005-01-19
PT1121107E (pt)	2004-02-27
NZ510756A (en)	2003-05-30
JP3792514B2 (ja)	2006-07-05
AU5643699A (en)	2000-05-01
MA26698A1 (fr)	2004-12-20
ATE254453T1 (de)	2003-12-15
DE69912978T2 (de)	2004-04-22
EE04868B1 (et)	2007-08-15
DZ2913A1 (fr)	2004-03-01
TR200101090T2 (tr)	2001-12-21
EA200100285A1 (ru)	2001-10-22
HK1040199A1 (en)	2002-05-31
KR100417200B1 (ko)	2004-02-05
MY122477A (en)	2006-04-29
WO2000021521A3 (en)	2000-07-20
CZ20011286A3 (cs)	2001-09-12
YU26401A (sh)	2005-07-19
CO5150213A1 (es)	2002-04-29
AR014082A1 (es)	2001-01-31
PA8483301A1 (es)	2000-09-29
TWI228043B (en)	2005-02-21
IS2239B (is)	2007-05-15
PY990106A (es)	2007-11-01
EA003990B1 (ru)	2003-12-25
GEP20032969B (en)	2003-05-27
PL348119A1 (en)	2002-05-06
HUP0104470A2 (en)	2002-08-28
EP1121107A2 (en)	2001-08-08
SK4582001A3 (en)	2002-02-05
KR20010080096A (ko)	2001-08-22
BG105434A (bg)	2001-12-29
NO20011829D0 (no)	2001-04-10
AP2001002119A0 (en)	2001-03-22
NO20011829L (no)	2001-06-05
UA72743C2 (en)	2005-04-15
HK1040199B (zh)	2005-05-27
GC0000175A (en)	2006-03-29

Legal Events

Date	Code	Title	Description
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2009-02-16	KB4A	Valid patent at the end of a year	Effective date: 20081231
2009-06-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20080922

Publication	Publication Date	Title
ID26936A (id)	2001-02-22	Komposisi herbisida konsentrat
ID26720A (id)	2001-02-01	Komposisi oral
ATE252333T1 (de)	2003-11-15	Zahnbürste
DE69827672D1 (de)	2004-12-23	Teleskopartiges intraorales kraftelement
DE69934002D1 (de)	2006-12-28	Zahnbürste
IS5555A (is)	2000-06-30	Selekoxib lyfjablöndur
ID30031A (id)	2001-11-01	Formulasi-formulasi agrokimia
FR2773466B1 (fr)	2000-10-20	Etrier orthodontique auto-ligaturant
DE69934771D1 (de)	2007-02-22	Zahnbürste
NO20004240D0 (no)	2000-08-24	Formuleringer
ATE224703T1 (de)	2002-10-15	Brauseformulierungen
PT1130966E (pt)	2005-04-29	Formulacoes antiparasitarias
DE60007530D1 (de)	2004-02-05	Oral wirksame androgene
DE69920345D1 (de)	2004-10-28	Fräsmeissel
ATE217021T1 (de)	2002-05-15	Präparationsmittel
DK1121107T3 (da)	2004-02-23	Oralt sertralin-koncentrat
IS5260A (is)	1999-11-19	Uppleystar sertralín samsetningar
FR2782671B3 (fr)	2000-07-21	Livre
ID23306A (id)	2000-04-05	Turunan-turunan di- atau triaza-spiro dekana
FI980856A0 (fi)	1998-04-17	Andningsskydd utrustad med en identifierare
IS5877A (is)	2001-03-05	Ný efnablanda
DE59901177D1 (de)	2002-05-16	Zahnbürste
ATE254866T1 (de)	2003-12-15	Zahnbürste
IS5879A (is)	2001-03-07	Ný efnablanda
NO995788D0 (no)	1999-11-25	Arbeidsbord